PARATEK PHARMACEUTICALS, INC. — Revenue by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/cfa07b67-a350-4ec4-a439-91a5c6ec03a1/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2022 | $160.3M | 2022-01-01 – 2022-12-31 | evidence 0001628280-23-008187 |
| FY 2021 | $130.2M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-009957 |
| FY 2020 | $46.9M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-016154 |
| FY 2019 | $16.5M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-009802 |
| FY 2018 | $17.1M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-006315 |
| FY 2017 | $12.6M | 2017-01-01 – 2017-12-31 | evidence 0001564590-19-006315 |
| FY 2016 | $29.0k | 2016-01-01 – 2016-12-31 | evidence 0001564590-17-003144 |
| FY 2014 | $4.3M | 2014-01-01 – 2014-12-31 | evidence 0001564590-17-003144 |
| FY 2013 | $-5.1M | 2013-01-01 – 2013-12-31 | evidence 0001178711-14-000011 |
| FY 2012 | $9.6M | 2012-01-01 – 2012-12-31 | evidence 0001178711-13-000012 |
| FY 2011 | $19.7M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-143822 |
| FY 2010 | $12.5M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-143822 |
| FY 2009 | $5.2M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-143822 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
PARATEK PHARMACEUTICALS, INC. — all facts · Net Income · Operating Income